Sign in

CIK 0001824293 · <br>Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824369909
Phone
(619) 400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 8-K Event Executive or director change · Shareholder vote results
  3. ARS Other Annual Report to Security Holders
  4. DEF 14A Proxy Proxy Statement
  5. 8-K Event Regulation FD disclosure · Other events
  6. 10-Q Report Quarterly Report
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 8-K Event Other events
  9. 8-K Event Results of operations · Other events
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 10-Q Report Quarterly Report
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Results of operations
  15. EFFECT Other Notice of Effectiveness
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. 10-K Report Annual Report
  19. 8-K Event Material agreement
  20. 424B5 Offering Prospectus

Page 1 of 21 · 403 filings